In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 67 for your search:
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 70
Sponsor: NIGMS
Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: S07-002, 1098558, NCT00882596
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 45 and over
Sponsor: Other
Protocol IDs: Mammosite ML, NCT01448447
4.

Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P0334, NCT01501487
5.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTPR-0009, NCT01644669
6.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000409590, NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCT00103181
8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 96/84 Graham, NCT00138814
9.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TROG 07.01, NHMRC 454390, BIG 3-07, NCIC CTG MA.33, BOOG 2009-03, ICORG 10-06, EORTC 22085-10083, IBCSG 38-10, SCTBG 2009MayPR55, NCT00470236
10.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: SU-12102007-930, 98272, BRSNSTU0025, NCT00695916
11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00702, NSABP-B-43, CDR0000615085, U10CA012027, NCT00769379
12.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4126, NCT00757302
13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000636007, INCA-BONBIS, RECF0911, VA-2008/25, ID-RCB-2008-A00494-51, BONBIS, NCT00907868
14.

Phase: Phase III
Type: Diagnostic, Health services research, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: IGR IRCIS 1503, NCT01112254
15.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 2009-APBI, WIRB #20091193, NCT01185132
16.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1005, NCI-2011-02669, CDR0000700069, NCT01349322
17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: S12-01299, NCT01591811
18.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: GBG 54, 2009-015122-11, NCT01638247
19.

Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: UAMS 07050, NIH Grant 5 R21 CA097715-01, NCT00574301
20.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644921, UPCC-15107, 807010, NCT00923143
21.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Adult
Sponsor: Other
Protocol IDs: 2008NTLS083, UMN-0809M45461, UMN-2008NTLS083, NCT01009437
22.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IFHCC 09-002, NCT01023477
23.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 41 and over
Sponsor: Other
Protocol IDs: 12-001 Single Fraction IORT, NCT01688388
24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 40 to 85
Sponsor: Other
Protocol IDs: BRT-HDR, NCT00499057
25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and over
Sponsor: Other
Protocol IDs: 0601000957, NCT00611624
1    
New Search